FindTrial
Sign In

SERUM PROCALCITONIN LEVELS AND CHANGES IN HEMATOCRIT IN PREDICTION OF SEVERITY OF ACUTE PANCREATITIS

EVALUATION OF SERUM PROCALCITONIN LEVELS AND CHANGES IN HEMATOCRIT IN PREDICTION OF SEVERITY OF ACUTE PANCREATITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038692
Enrollment
50
Registered
2021-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K859- Acute pancreatitis, unspecified

Interventions

None listed

Sponsors

ABVIMS Dr Ram Manohar Lohia Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients above 18 years with acute pancreatitis

Exclusion criteria

Exclusion criteria: recurrent acute pancreatitis Chronic pancreatitis Patients having other co existing condition which can raise procalcitonin levels (eg other sources of sepsis, major trauma, major surgical intervention, severe burns, prolonged or severe organ perfusion abnomralities, small cell lung cancer or medullary C cell carcinoma of thyroid)

Design outcomes

Primary

MeasureTime frame
Severity of disease as judged by length of hospital stayTimepoint: Time taken for complete recovery or mortality—

Secondary

MeasureTime frame
Severity of disease Complications MortalityTimepoint: 03 months—

Countries

India

Contacts

Public ContactDr Abhishek Prakash

ABVIMS and Dr RML Hospital

drguptaarunkumar@gmail.com8586970601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026